Keyphrases
Receptor Antagonist
93%
Binge-like
85%
Alcohol-preferring Rats
66%
N-methylation
66%
Impulsive Choice
66%
Immediate Reward
66%
Ketamine
66%
Memantine
66%
Aspartic Acid
66%
Alcohol
66%
Antagonism
66%
Pharmacological Characterization
66%
Sigma-1 Receptor
66%
Eating
66%
Access Model
66%
Intermittent Access
66%
Naltrexone
53%
Binge Drinking
40%
Alcohol Drinking
40%
BD-1063
38%
Binge Eating
28%
SCH 39166
26%
R121919
26%
Drinking Groups
26%
Competitive Antagonist
25%
Mechanism of Action
21%
Conflict Test
19%
Anterior Cingulate Cortex
19%
Protein Expression
19%
Palatable Food
19%
Light-dark
19%
MRNA Expression
19%
Eating Rate
19%
Wistar Rats
17%
Impulse Response
16%
Treatment Dose
16%
AP-5
16%
Delay Task
16%
Pharmacological Response
13%
Corticotropin Releasing Factor Receptor 1 (CRFR1)
13%
Dopamine D1 Receptor
13%
Adult Male
13%
Opioid Receptors
13%
Breath Alcohol Concentration (BrAC)
13%
Ethanol
13%
Continued Access
13%
Motivation
13%
Opioid Antagonist
13%
Alcohol Dependence
13%
Receptor-mediated
13%
Neuroscience
Receptor Antagonist
100%
Ketamine
66%
Memantine
66%
Anterior Cingulate Cortex
66%
Naltrexone
66%
Protein Expression
66%
Binge Eating Disorder
66%
Sigma 1 Opiate Receptor
66%
Dextro Aspartic Acid
66%
Messenger RNA
66%
Receptor
44%
Operant Conditioning
33%
Brain Areas
33%
Dopamine Receptor
16%
Fibrinogen
16%
Corticotropin-Releasing Hormone
16%
Dopamine Receptor D1
16%
Corticotropin-Releasing Hormone Receptor 1
16%
Narcotic Antagonist
16%
Impulsivity
11%
Behavior (Neuroscience)
11%
Medicine and Dentistry
Naltrexone
66%
Drinking Behavior
50%
Binge Drinking
50%
3 (6 Dimethylamino 4 Methyl 3 Pyridinyl) 7 Dipropylamino 2,5 dimethylpyrazolo[1,5 A]pyrimidine
33%
Corticotropin Releasing Factor
16%
Corticotropin Releasing Factor Receptor 1
16%
Treatment Response
16%
Dopamine 1 Receptor Blocking Agent
16%
Water Intake
16%
Opiate Antagonist
16%
Receptor Antagonist
16%
Dopamine Receptor
16%
Fibrinogen
16%